CoinVoice has recently learned that Strategic ETH Reserve published on platform X, stating that the NASDAQ-listed Ethereum treasury company ETHZilla (formerly 180 Life Sciences Corp.) has revised its previous sales agreement with Clear Street, involving the supplemental documents for the prospectus and the accompanying prospectus for the issuance of common stock with a par value of $0.0001 per share.

According to the terms of the revised sales agreement, the company will be able to raise up to $10,000,000,000 through the issuance and sale of common stock shares to support its continued purchase of ETH. [Original link]